← All trials
NCT00813566
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 12, 2010
- Primary completion
- Feb 3, 2015
- Completion date
- Feb 3, 2015
- First posted
- Dec 23, 2008
- Last posted
- Apr 27, 2022
- Enrollment
- 11
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of UtahLead sponsor
- University of UtahOverall official - principal investigator
- University of UtahStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.